Cargando…

Efficacy of Repeated Lusutrombopag Administration for Thrombocytopenia in a Patient Scheduled for Invasive Hepatocellular Carcinoma Treatment

The efficacy of repeated lusutrombopag administration for thrombocytopenia in patients with chronic liver disease who undergo two or more planned invasive procedures is unknown. We herein report our findings regarding the effects of repeated lusutrombopag administration given to avoid platelet trans...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Shuichi, Miyake, Tatsuya, Kataoka, Masatoshi, Isoda, Kazuki, Yazaki, Tomotaka, Tobita, Hiroshi, Ishimura, Norihisa, Kinoshita, Yoshikazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709632/ https://www.ncbi.nlm.nih.gov/pubmed/28943563 http://dx.doi.org/10.2169/internalmedicine.8791-16

Ejemplares similares

Combinational elastography for assessment of liver fibrosis in patients with liver injury
por: Yazaki, Tomotaka, et al.
Publicado: (2022)

Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive Procedures
por: Nishida, Yuno, et al.
Publicado: (2020)

Progression of Hepatic Hypovascular Nodules with Hypointensity in the Hepatobiliary Phase of Gd-EOB-DTPA-enhanced MRI in Hepatocellular Carcinoma Cases
por: Saitoh, Tsukasa, et al.
Publicado: (2017)

Efficacy and safety of repeated use of lusutrombopag prior to radiofrequency ablation in patients with recurrent hepatocellular carcinoma and thrombocytopenia
por: Ishikawa, Toru, et al.
Publicado: (2019)

Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study
por: Nomoto, Hiroaki, et al.
Publicado: (2020)

Effects of Dapagliflozin on Body Composition and Liver Tests in Patients with Nonalcoholic Steatohepatitis Associated with Type 2 Diabetes Mellitus: A Prospective, Open-label, Uncontrolled Study
por: Tobita, Hiroshi, et al.
Publicado: (2017)

Lusutrombopag for thrombocytopenia in Chinese patients with chronic liver disease undergoing invasive procedures
por: Ding, Zhenbin, et al.
Publicado: (2022)

Oxaliplatin-related Portal Hypertension Complicated with Esophageal Varices and Refractory Massive Ascites
por: Yazaki, Tomotaka, et al.
Publicado: (2022)

A cost‐effectiveness analysis of lusutrombopag for thrombocytopenia in patients with chronic liver disease in Japan
por: Miki, Norikane, et al.
Publicado: (2021)

Proton pump inhibitor is a risk factor for recurrence of common bile duct stones after endoscopic sphincterotomy – propensity score matching analysis
por: Fukuba, Nobuhiko, et al.
Publicado: (2017)

Retained Rice Cake: A Unique Upper Gastrointestinal Foreign Body: Case Report and a Literature Review
por: Oka, Akihiko, et al.
Publicado: (2019)

Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L‐PLUS 2)
por: Peck‐Radosavljevic, Markus, et al.
Publicado: (2019)

A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series
por: Biolato, Marco, et al.
Publicado: (2022)

Case-control study of association of eosinophilic gastrointestinal disorders with Helicobacter pylori infection in Japan
por: Furuta, Kenji, et al.
Publicado: (2013)

Relationship between response to lusutrombopag and splenic volume
por: Uojima, Haruki, et al.
Publicado: (2018)

Bleeding events in lusutrombopag‐treated thrombocytopenic patients
por: Giannini, Edoardo Giovanni, et al.
Publicado: (2021)

Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
por: Kinoshita, Yoshikazu, et al.
Publicado: (2018)

Primary Extragastrointestinal Stromal Tumor of Greater Omentum with Intraperitoneal Bleeding
por: Kataoka, Masatoshi, et al.
Publicado: (2021)

Systematic Review with Meta-Analysis: Efficacy and Safety of Lusutrombopag for Severe Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures
por: Orme, Michelle E., et al.
Publicado: (2022)

Association of lysophosphatidic acid molecules with liver fibrosis: different roles indicated
por: Tobita, Hiroshi, et al.
Publicado: (2023)

Safety and effectiveness of lusutrombopag in Japanese chronic liver disease patients with thrombocytopenia undergoing invasive procedures: Interim results of a postmarketing surveillance
por: Sasaki, Ritsue, et al.
Publicado: (2019)

Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
por: Sakamaki, Akira, et al.
Publicado: (2017)

Assessing the periprocedural magnitude of platelet count change in response to lusutrombopag
por: Brown, Robert S., et al.
Publicado: (2021)

Successful Transanal Removal of a Rectal Foreign Body by Abdominal Compression under Endoscopic and X-Ray Fluoroscopic Observation: A Case Report
por: Mikami, Hironobu, et al.
Publicado: (2016)

Long-lasting renal dysfunction following tacrolimus induction therapy in ulcerative colitis patients
por: Cha, Na, et al.
Publicado: (2022)

A study on prevention of bleeding complications using lusutrombopag for safe RFA in patients with hepatocellular carcinoma with low platelet counts: prospective observational study
por: Yoshida, Hideo, et al.
Publicado: (2023)

Retinol Supplements Antiviral Action of Interferon in Patients with Chronic Hepatitis C: A Prospective Pilot Study
por: Kohge, Naruaki, et al.
Publicado: (2010)

Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures
por: Katsube, Takayuki, et al.
Publicado: (2019)

Lusutrombopag (Mulpleta®) treatment in a patient with thrombocytopenia complicated by cirrhosis prior to continuous epidural anesthesia during renal artery embolization: a case report
por: Sasaguri, Tomoko, et al.
Publicado: (2018)

Lusutrombopag as a substitute for platelet transfusion for thrombocytopenia associated with chronic liver disease in a patient undergoing endoscopic spinal surgery: A case report
por: Kaneko, Takeshi, et al.
Publicado: (2021)

A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation
por: Tateishi, Ryosuke, et al.
Publicado: (2018)

The Simultaneous Onset of Pancreatitis and Colitis as Immune-related Adverse Events in a Patient Receiving Nivolumab Treatment for Renal Cell Carcinoma
por: Yazaki, Tomotaka, et al.
Publicado: (2021)

Administration of PPARβ/δ agonist reduces copper-induced liver damage in mice: possible implications in clinical practice
por: Sanchez-Siles, Alvaro A., et al.
Publicado: (2011)

Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders
por: Shimura, Shino, et al.
Publicado: (2016)

Application of Convolutional Neural Networks for Diagnosis of Eosinophilic Esophagitis Based on Endoscopic Imaging
por: Okimoto, Eiko, et al.
Publicado: (2022)

Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, in Rats by UPLC-MS/MS
por: Wang, Bo, et al.
Publicado: (2020)

Effects of Lusutrombopag on Post-invasive Procedural Bleeding in Thrombocytopenic Patients with Chronic Liver Disease
por: Yoshida, Manami, et al.
Publicado: (2021)

Magnification endoscopy in combination with acetic acid enhancement and narrow-band imaging for the accurate diagnosis of colonic neoplasms
por: Shibagaki, Kotaro, et al.
Publicado: (2020)

Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance
por: Mikami, Hironobu, et al.
Publicado: (2018)

Serological screening for celiac disease in adults in Japan: Shimane CoHRE study
por: Fukunaga, Mai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lg05395ocfe8n2huvf4n8qd1ok